Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Erik Renström

Erik Renström

Vice-chancellor

Erik Renström

Reduced Insulin Exocytosis in Human Pancreatic β-cells With Gene Variants Linked to Type 2 Diabetes.

Author

  • Anders Rosengren
  • Matthias Braun
  • Taman Mahdi
  • Sofia A Andersson
  • Mary E Travers
  • Makoto Shigeto
  • Enming Zhang
  • Peter Almgren
  • Claes Ladenvall
  • Annika Axelsson
  • Anna Edlund
  • Morten Gram Pedersen
  • Anna Jonsson
  • Reshma Ramracheya
  • Yunzhao Tang
  • Jonathan N Walker
  • Amy Barrett
  • Paul R V Johnson
  • Valeriya Lyssenko
  • Mark I McCarthy
  • Leif Groop
  • S Albert Salehi
  • Anna L Gloyn
  • Erik Renström
  • Patrik Rorsman
  • Lena Eliasson

Summary, in English

The majority of genetic risk variants for type 2 diabetes (T2D) affect insulin secretion, but the mechanisms through which they influence pancreatic islet function remain largely unknown. We functionally characterized human islets to determine secretory, biophysical, and ultrastructural features in relation to genetic risk profiles in diabetic and nondiabetic donors. Islets from donors with T2D exhibited impaired insulin secretion, which was more pronounced in lean than obese diabetic donors. We assessed the impact of 14 disease susceptibility variants on measures of glucose sensing, exocytosis, and structure. Variants near TCF7L2 and ADRA2A were associated with reduced glucose-induced insulin secretion, whereas susceptibility variants near ADRA2A, KCNJ11, KCNQ1, and TCF7L2 were associated with reduced depolarization-evoked insulin exocytosis. KCNQ1, ADRA2A, KCNJ11, HHEX/IDE, and SLC2A2 variants affected granule docking. We combined our results to create a novel genetic risk score for β-cell dysfunction that includes aberrant granule docking, decreased Ca(2+) sensitivity of exocytosis, and reduced insulin release. Individuals with a high risk score displayed an impaired response to intravenous glucose and deteriorating insulin secretion over time. Our results underscore the importance of defects in β-cell exocytosis in T2D and demonstrate the potential of cellular phenotypic characterization in the elucidation of complex genetic disorders.

Department/s

  • Diabetes - Islet Patophysiology
  • Diabetes - Islet Cell Exocytosis
  • Genomics, Diabetes and Endocrinology
  • Islet cell physiology
  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2012

Language

English

Pages

1726-1733

Publication/Series

Diabetes

Volume

61

Issue

7

Document type

Journal article

Publisher

American Diabetes Association Inc.

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Diabetes - Islet Patophysiology
  • Diabetes - Islet Cell Exocytosis
  • Genomics, Diabetes and Endocrinology
  • Islet cell physiology

ISBN/ISSN/Other

  • ISSN: 1939-327X